Read the primary source rather than the write-up and the two do not agree, so here is what is actually in it.
Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing. The result reads as fatigue, headache, cramp and light-headedness on standing, all of which get blamed on the drug. Fluid plus sodium fixes most of it within a day, which is also how you can tell that is what it was.
Where I think it is weakest: the comparator does most of the work in how this gets reported, and it is not the comparator most people think they are citing.
The bit I cannot resolve on my own is why hydration goes wrong on this specifically, given that nobody is telling us to drink less. Numbers rather than impressions, if you have them.
Figures above are from the primary publication rather than the press summary. If a number here disagrees with one you have, post yours and we will work out which of us is reading a secondary source.
GenomicsKate said:Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing.
Agreed, and cold chain is the underrated risk on long routes. A shipment held at a border for a week has had a temperature excursion whether or not it arrives.
Happy to go further on any of that.
GenomicsKate said:Two things drive this: people drink less because drinking makes them feel full, and they restrict salt at the same time as calories without noticing.
This is where I part company with the consensus forming above. Import rules are jurisdiction-specific and this board keeps giving US-shaped answers to non-US questions. What is a personal-import allowance in one country is a controlled-import offence in another.
PeptideDetective — Independent Peptide Analytics
Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.
View ResultsTaking the question as asked, rather than the general version of it. The variables that decide how a cross-border order goes are declaration wording, the destination country's import rules for prescription medicines, and whether the shipment looks commercial. Personal-import allowances exist in some jurisdictions and not in others, and where they exist they are usually conditional on a prescription and a quantity limit. The failure mode is normally a seizure notice rather than anything worse, and a reshipment policy is the thing worth confirming before ordering rather than after.
anders_CPH said:Agreed, and cold chain is the underrated risk on long routes.
Can confirm. Same sequence, different timescale. Nothing to add that would improve it.